Pacira | Spese Operative



Operating Expenses Cambiamento Data
Astellas Pharma JPY 395.77B 237.82B 2025-03
Bristol-Myers Squibb USD 8.23B 3.32B 2025-03
Ironwood Pharmaceuticals USD 57.33M 8.63M 2024-12
J&J USD 8.26B 10.37B 2025-03
Ligand Pharmaceuticals USD 81.55M 29.1M 2025-03
Novo Nordisk 39.3B 1.81B 2025-03
Pacira USD 166.93M 4.38M 2025-03
Perrigo USD 1.03B 13.4M 2024-12
Pfizer USD 10.05B 8.12B 2025-03
Supernus Pharmaceuticals USD 152.75M 17.91M 2024-12
Teva Pharmaceutical Industries USD 3.37B 402M 2025-03
Xeris Pharmaceuticals USD 58.42M 8.74M 2024-12
Zoetis USD 1.41B 175M 2025-03



Pacira Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.